Option Care Health, Inc. (NASDAQ:OPCH - Free Report) - Equities researchers at William Blair raised their FY2025 earnings estimates for shares of Option Care Health in a research report issued on Wednesday, April 30th. William Blair analyst M. Larew now expects that the company will post earnings per share of $1.52 for the year, up from their previous estimate of $1.49. The consensus estimate for Option Care Health's current full-year earnings is $1.22 per share. William Blair also issued estimates for Option Care Health's Q4 2025 earnings at $0.43 EPS, Q1 2026 earnings at $0.44 EPS, Q2 2026 earnings at $0.41 EPS, Q3 2026 earnings at $0.48 EPS and FY2026 earnings at $1.85 EPS.
Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The company had revenue of $1.33 billion for the quarter, compared to analysts' expectations of $1.26 billion. During the same period in the prior year, the firm earned $0.26 earnings per share. The firm's revenue for the quarter was up 16.3% on a year-over-year basis.
Other analysts have also issued reports about the stock. Barrington Research reiterated an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research note on Wednesday, April 30th. JMP Securities reaffirmed a "market outperform" rating and set a $36.00 price target on shares of Option Care Health in a research report on Tuesday, April 22nd. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and lifted their price target for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. Finally, JPMorgan Chase & Co. increased their target price on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. One research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat, Option Care Health presently has a consensus rating of "Moderate Buy" and an average price target of $35.50.
Read Our Latest Research Report on OPCH
Option Care Health Stock Up 0.8 %
Option Care Health stock traded up $0.27 during mid-day trading on Friday, reaching $33.01. The stock had a trading volume of 512,330 shares, compared to its average volume of 1,826,007. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The company has a market capitalization of $5.40 billion, a price-to-earnings ratio of 27.71, a PEG ratio of 2.30 and a beta of 0.76. Option Care Health has a one year low of $21.39 and a one year high of $35.53. The company has a 50-day moving average price of $33.33 and a two-hundred day moving average price of $28.85.
Institutional Investors Weigh In On Option Care Health
Several large investors have recently bought and sold shares of OPCH. Murphy & Mullick Capital Management Corp acquired a new position in Option Care Health in the fourth quarter valued at approximately $26,000. UMB Bank n.a. grew its position in Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after acquiring an additional 346 shares in the last quarter. Signaturefd LLC increased its stake in Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after purchasing an additional 1,005 shares during the period. Quadrant Capital Group LLC boosted its position in Option Care Health by 172.8% in the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after buying an additional 1,099 shares during the period. Finally, Public Employees Retirement System of Ohio grew its stake in shares of Option Care Health by 21.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after acquiring an additional 332 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity
In other news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now owns 44,974 shares of the company's stock, valued at $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 0.64% of the company's stock.
Option Care Health Company Profile
(
Get Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Read More

Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.